In addition, the dysfunction of the nuclear factor erythroid 2-related factor 2 (NRF2) antioxidant defense pathway in endothelial cells might also play a role in the COVID-19 associated endotheliopathy [28]. The gene discussed is NFE2L2; the disease is COVID-19.